Aging and Lung Disease: Clinical Impact and Cellular and Molecular Pathways

描述(由申请人提供)： 这项申请要求为2014年匹兹堡-慕尼黑肺病会议提供部分资金，题为“衰老与肺部疾病：临床影响以及细胞和分子途径”。大会将于2014年10月23日至24日在宾夕法尼亚州匹兹堡的大学俱乐部举行。预计出席人数为300-400人，包括基础科学家、内科科学家、临床医生、 和其他健康专业人士。演讲者和与会者将是初级和高级调查人员以及专门从事广泛科学学科(细胞生物学、遗传学、 医学、肺科、老年病学、公共卫生)。本次会议代表着第13届匹兹堡肺病年会，将肺部疾病和老龄化领域的尖端科学独特地融合在一起。本次会议的具体议题包括：(1)衰老的“OMICS”；(2)年龄、遗传学和肺部疾病；(3)细胞衰老的分子驱动因素及其对呼吸系统的影响；(4)线粒体与衰老；(5)肺部疾病与衰老；(6)衰老干细胞与肺修复。我们相信，这次会议是独特的、及时的和非常重要的，因为它将把衰老细胞生物学、遗传学、肺病学、老年病学社区中公认的专家聚集在一个旨在传播新信息和促进现有研究人员和初级研究人员互动的场所。这次会议将为未来与年龄相关的肺部疾病研究提供新的方法和方向的框架。

DESCRIPTION (provided by applicant): This application requests partial funding for the 2014 Pittsburgh-Munich Lung Conference entitled "Aging and Lung Disease: Clinical Impact, and Cellular and Molecular Pathways." The conference will be held on October 23-24, 2014, at the University Club in Pittsburgh, PA. Expected attendance is 300-400 and will include basic scientists, physician-scientists, clinicians, and other health professionals. Speakers and attendees will be junior and senior investigators as well as trainees specializing in a wide range of scientific disciplines (cell biology, genetics, medicine, pulmonary, geriatrics, public health). This Conference represents the 13th annual Pittsburgh Lung meeting with a unique blend of cutting-edge science in the field of pulmonary diseases and aging. The specific topics to be covered in this conference include: (1) "OMICS" of aging; (2) Age, genetics and lung diseases; (3) Molecular drivers of cell aging, and their impact in the respiratory system; (4) Mitochondria and aging; (5) Lung diseases and aging; (6) Aging stem cells and lung repair. We believe that this meeting is unique, timely, and highly important because it will bring together recognized experts within the aging-cell biology, genetics, pulmonary, geriatrics communities in a venue designed to both disseminate new information and to promote the interaction of established and junior investigators. This meeting will provide a framework for novel approaches and directions for future age-related lung diseases research.